Earnings call transcript: Mowi Q1 2026 shows strong revenue amid industry headwinds

Mowi reported record Q1 2026 revenue of EUR 1.54 billion and operational EBIT of EUR 221 million, with underlying EPS of EUR 0.27 and blended farming cost down 7.3% year over year to EUR 5.46/kg. The company kept 2026 volume guidance at 605,000 tonnes and signaled lower costs in the second half, while approving a NOK 2.30 quarterly dividend. Near-term pricing remains pressured by 14% industry supply growth, but the stock is described as undervalued and was down 0.36% to EUR 192.85.

Analysis

The key implication is not simply that the quarter was good, but that supply discipline is finally reasserting itself after a period of overhang. In a commodity-like market, the combination of lower harvest-ready biomass and improving cost structure tends to matter more than one quarter of price weakness, because margin expansion usually arrives with a lag once the market recognizes the tighter forward balance. The market appears to still be pricing Mowi as if elevated supply persists, which is why a low multiple can coexist with a weak tape.

The second-order winner is the cost-advantaged producer with the most flexible downstream mix. Mowi’s integrated model should let it capture a larger share of any recovery than pure farming peers: when spot prices firm, the farming segment re-rates first, while consumer and feed operations add earnings stability and reduce the multiple penalty associated with commodity exposure. That makes the stock more attractive as a “quality cyclicals” expression than as a simple salmon-beta trade.

The main risk is timing, not direction. If supply normalization is slower than implied, or if input inflation from freight, marine ingredients, or biology re-accelerates into Q2/Q3, the earnings inflection gets pushed out and the market will keep assigning a discount for another 1-2 quarters. Conversely, any sign that the upcoming biomass data confirms tighter harvest availability should catalyze a sharp rerating because current expectations look anchored to the wrong part of the cycle.

The contrarian view is that the market may be underestimating how quickly fixed-cost dilution can amplify earnings once volume and pricing both move in the right direction. This is a setup where modest operational improvement can translate into outsized EPS upside, especially with leverage already near target and capital returns intact. The stock is not pricing a disruption story; it is pricing a normalization story that may already be late.

Key Decisions for Investors

• Long Mowi ASA (0OAW) on a 3-6 month horizon; add on any post-earnings consolidation or if the stock retraces toward the low-180s, targeting a re-rating toward mid-teens P/E as forward supply data tightens. Risk: a delay in supply normalization or renewed biology issues could keep the multiple compressed.
• Pair trade: long Mowi / short a higher-cost salmon producer or basket of weaker aquaculture names over the next 1-2 quarters, using Mowi’s cost leadership and balance sheet as the quality leg. Risk/reward favors Mowi if industry prices stabilize even modestly because operating leverage should widen the spread.
• Use call spreads on Mowi for Q3-Q4 catalysts rather than outright equity if you want defined downside: buy 6-month calls and finance with out-of-the-money upside sales. This captures the likely earnings inflection while limiting exposure if the market stays supply-focused longer than expected.
• If tracking the space for a broader consumer staple hedge, avoid shorting salmon beta outright until the next biomass readout; the cleaner trade is short the weakest balance-sheet names against Mowi. The asymmetric risk is that the whole group rallies on tighter supply, but Mowi should outperform on quality and capital returns.